Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition

Article

Mylan proposed to acquire Perrigo for $205 per share in a cash-and-stock transaction on April 6, 2015.

PRESS RELEASE

POTTERS BAR, England, April 13, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that it has provided Perrigo Company plc (NYSE: PRGO; TASE) with notice of its filing today of the premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with the U.S. Federal Trade Commission and the U.S. Department of Justice Antitrust Division regarding its proposed acquisition of Perrigo, as required by the HSR Act. Mylan proposed to acquire Perrigo for $205 per share in a cash-and-stock transaction on April 6, 2015.

Mylan Executive Chairman Robert J. Coury stated, "As we continue to await for Perrigo's Board of Directors' deliberations to be complete, today's filing represents another important step in our ongoing determination to make this compelling proposed combination a reality. We are eager to continue our prior discussions with Perrigo as soon as possible and to mutually agree on the way forward."

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.